Intuitive Surgical Current Deferred Revenue Over Time
| ISRG Stock | USD 542.00 3.45 0.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Intuitive Surgical Performance and Intuitive Surgical Correlation. Intuitive |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.345 | Earnings Share 6.19 | Revenue Per Share 22.22 | Quarterly Revenue Growth 0.169 | Return On Assets 0.0795 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Current Deferred Revenue Analysis
Compare Intuitive Surgical and related stocks such as Repligen, ResMed Inc, and Merit Medical Systems Current Deferred Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RGEN | 38.6 K | 599.1 K | 599.1 K | 3.3 K | 129.9 K | 258 K | 408 K | 960 K | 1.3 M | 5 M | 15.3 M | 14.8 M | 19.3 M | 10.3 M | 5.4 M |
| RMD | 6.4 M | 41.6 M | 45 M | 42.4 M | 36.1 M | 50 M | 51.9 M | 60.8 M | 88.7 M | 98.6 M | 109.6 M | 108.7 M | 138.1 M | 152.6 M | 160.2 M |
| MMSI | 4.8 M | 551 K | 551 K | 292 K | 381 K | 589 K | 572 K | 4.6 M | 4.6 M | 4.6 M | 4.6 M | 5.1 M | 5.1 M | 4.6 M | 3.9 M |
| ICUI | 2.4 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.8 M | 6.7 M | 5.6 M | 12.6 M | 30.8 M | 31.6 M | 33.2 M |
| BNGO | 446.8 K | 446.8 K | 446.8 K | 446.8 K | 446.8 K | 446.8 K | 446.8 K | 211.7 K | 271 K | 357.5 K | 415.5 K | 684 K | 871 K | 783 K | 555.6 K |
| LUCY | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 30 K | 42.5 K | 39.9 K |
| STXS | 1.7 M | 8.2 M | 9.5 M | 7.5 M | 6.7 M | 7.4 M | 8.8 M | 5.7 M | 5.8 M | 5.1 M | 5.3 M | 6.3 M | 7.3 M | 6.7 M | 6.9 M |
| NXGL | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 14 K | 38 K | 54 K | 20 K | 23 K | 34.6 K |
| EMBC | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (1000 K) | (900 K) | (945 K) |
| BAX | 1.7 B | 738 M | 878 M | 760 M | 9 M | 2.4 B | 1.9 B | 228 M | 234 M | 32 M | 32 M | 162 M | 164 M | 148 M | 140.6 M |
| WST | 25.2 M | 64.3 M | 82.7 M | 83.4 M | 13.3 M | 14.4 M | 13.2 M | 18.4 M | 25.5 M | 27.5 M | 51 M | 48.7 M | 57.3 M | 41.7 M | 38.2 M |
| COO | 65.6 M | (85.1 M) | (108.2 M) | (116.4 M) | (116.9 M) | (107.4 M) | (142.1 M) | (146.4 M) | (150.1 M) | (176 M) | (161.4 M) | 93.6 M | 123.6 M | 111.2 M | 116.8 M |
| TFX | 129.3 M | 198.3 M | 165.6 M | 180.5 M | 180.8 M | 164.2 M | 166.2 M | 221.9 M | 5.9 M | 228.7 M | 283.1 M | 396.2 M | 41.5 M | 47.7 M | 45.3 M |
| BDX | 310.2 M | 3.9 M | 19 M | 1.6 B | 2.3 B | 2.5 B | 176 M | 343 M | (1.1 B) | (1.4 B) | (1.8 B) | (1.6 B) | (1.6 B) | (1.5 B) | (1.4 B) |
| HOLX | 8.8 M | 129.7 M | 132.3 M | 150.9 M | 163.1 M | 161.4 M | 171.2 M | 172.9 M | 179.5 M | 186.1 M | 198 M | 186.5 M | 199.2 M | 212.9 M | 132.4 M |
Intuitive Surgical and related stocks such as Repligen, ResMed Inc, and Merit Medical Systems Current Deferred Revenue description
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.My Equities
My Current Equities and Potential Positions
| Intuitive Surgical | ISRG |
| Classification | Obamacare Repeal |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 542.0
Check out Intuitive Surgical Performance and Intuitive Surgical Correlation. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Intuitive Surgical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.